Cytogen, Inc. (KOSDAQ:217330)

South Korea · Delayed Price · Currency is KRW

3,055.00

-35.00 (-1.13%)

At close: Sep 11, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Liquid Biopsy Application Business	12.42B	5.12B	866.06M	615.15M	347.85M
Genome Technology Development and Analysis Services	10.96B	3.59B	-	-	-
Toxicity and Molecular Diagnostic Tests	2.67B	2.20B	2.32B	145.63M	-
Total	26.05B	10.91B	3.18B	760.78M	347.85M

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
South Korea	23.39B	8.71B	833.37M	565.65M	347.85M
USA	1.88B	2.20B	2.32B	157.74M	-
Asia	788.49M	-	32.69M	37.39M	-
Total	26.05B	10.91B	3.18B	760.78M	347.85M